Henry James International Management’s Core Laboratories CLB Stock Holding History

Henry James International Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37,800	Closed	-$1.2M	–	132
2022 Q1	$1.2M	Sell	37,800 -5,029	-12%	-$141K	0.47%	48
2021 Q4	$956K	Sell	42,829 -49,468	-54%	-$1.29M	0.29%	79
2021 Q3	$2.56M	Sell	92,297 -15,816	-15%	-$481K	0.81%	35
2021 Q2	$4.21M	Buy	108,113 +78,089	+260%	+$2.8M	1.2%	26
2021 Q1	$864K	Buy	+30,024	New	+$1.03M	0.26%	82

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Henry James International Management's CLB Position: Q2 2022 in Review

Henry James International Management sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 37,800 shares — an estimated $1.2M sold.

Henry James International Management first reported a position in CLB in Q1 2021 and held it in 5 quarters. The position peaked at $4.21M in Q2 2021. 176 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

Henry James International Management reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
Henry James International Management sold 37,800 Core Laboratories shares in Q2 2022, an estimated $1.2M.
Henry James International Management first reported a position in Core Laboratories in Q1 2021 and held it in 5 quarters.
Henry James International Management's Core Laboratories position peaked at $4.21M in Q2 2021.
176 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Henry James International Management's 13F filing for Q2 2022, filed 25 Jul 2022.